The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.

I. Adcock (London, United Kingdom), M. Main (Castle Cary, United Kingdom), A. Rothaul (Oxford, United Kingdom), C. Wiegman (London, United Kingdom), F. Morgan (Medfield, United States of America)

Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Session: Airway pharmacology: translational and basic science
Session type: E-poster
Number: 549

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Adcock (London, United Kingdom), M. Main (Castle Cary, United Kingdom), A. Rothaul (Oxford, United Kingdom), C. Wiegman (London, United Kingdom), F. Morgan (Medfield, United States of America). The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.. 549

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Syk is downstream of ICAM-1 and mediates human rhinovirus (HRV) activation of p38 MAP kinase in airway epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure
Source: Eur Respir J 2005; 25: 797-803
Year: 2005



YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK, ERK1/2) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012


Inhibition of c-kit tyrosine kinase by sunitinib alleviates airway remodeling in a mouse model of chronic asthma
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009



Corticosteroids reduce pro-inflammatory cytokine expression in airway smooth muscle cells via upregulation of MAPK phosphatase-1 and inhibition of p38 MAPK signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 713s
Year: 2005

Thrombin activates mitogen activated protein (MAP) kinase and activated protein-1 (AP-1) to induce interleukin-8 (IL-8) release from airway epithelial cells
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells
Source: Eur Respir J 2003; 22: 43-49
Year: 2003



The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008


RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-a and -? selectivity, suppresses COPD inflammation
Source: Eur Respir J, 50 (4) 1700188; 10.1183/13993003.00188-2017
Year: 2017



Involvement of NFkB activation and c-JUN phosphorylation in bronchial epithelial cells by CD-40-CD40L pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002

Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Involvement of protein kinase A (PKA) in the IL-1β induced MCP-1 production in human airway smooth muscle cells
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001

Exposure to LPS induces the upregulation of p38 MAPK in human bronchial epithelium in vivo
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003

Corticosteroid insensitivity and enhanced mitogen-activated protein kinase activity in airway smooth muscle cells of severe asthma
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011


TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021



Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Source: Eur Respir J 2010; 35: 750-756
Year: 2010



Regulation of cytokine- and phorbol ester-mediated interleukin (IL)-8 expression in the absence or presence of pyocyanin in human bronchial epithelial cell line: roles of protein kinase C and mitogen-activated protein kinases
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005